greeksoup/ stock research
Stock research / United States / URGN / Planned sales

UroGen Pharma Ltd. planned insider sales

In the last twelve months insiders at UroGen Pharma Ltd. filed 10 Form 144 notices of planned sales, 123,824 shares worth $4.8 million at the time of filing, from 4 sellers. The latest, filed 9 October 2026: Christopher Degnan (officer), 2,202 shares worth $89,621, planned for around 8 October 2026 through Oppenheimer & Co. Inc..

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
9 October 2026Christopher DegnanOfficer2,202$89,6218 October 20262,202 shares from 8 October 2026Oppenheimer & Co. Inc.Shares issued upon vesting of RSUsForm 144
9 September 2026Mark SchoenbergOfficer871$38,4028 September 2026871 shares from 8 September 2026Oppenheimer & Co. Inc.Shares issued upon vesting of RSUsForm 144
9 September 2026Jason SmithOfficer1,519$66,9738 September 20261,519 shares from 8 September 2026Oppenheimer & Co. Inc.Shares issued upon vesting of RSUsForm 144
20 August 2026Schoenberg MarkOfficer60,677$2.9 million20 August 202660,677 shares from 20 August 2026RBC CAPITAL MARKETS LLCSTOCK OPTION EXERCISEForm 144
9 July 2026Schoenberg MarkOfficer10,000$400,0089 July 202610,000 shares from 9 July 2026RBC CAPITAL MARKETS LLCSTOCK OPTION EXERCISEForm 144
22 June 2026Schoenberg MarkOfficer10,000$350,14322 June 202610,000 shares from 22 June 2026RBC CAPITAL MARKETS LLCSTOCK OPTION EXERCISEForm 144
9 June 2026Schoenberg MarkOfficer5,222$140,2118 June 20265,222 shares from 8 June 2026Oppenheimer & Co. Inc.Shares issued upon vesting of RSUsForm 144
8 May 2026Schoenberg MarkOfficer10,000$300,0488 May 202610,000 shares from 8 May 2026RBC CAPITAL MARKETS LLCOPTION EXERCISEForm 144
3 February 2026Schoenberg MarkOfficer13,333$261,4602 February 20267,373 shares from 3 February 2026Oppenheimer & Co. IncRSUForm 144
19 November 2025Schoenberg MarkOfficer10,000$250,00519 November 202510,000 shares from 19 November 2025RBC CAPITAL MARKETS LLCSTOCK OPTION EXERCISEForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?